Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
about
Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signaling in human prostate cancer cells.Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.Free Fatty Acid Receptor 1 (FFAR1) as an Emerging Therapeutic Target for Type 2 Diabetes Mellitus: Recent Progress and Prevailing Challenges.Free Fatty Acid Receptors and Cancer: From Nutrition to Pharmacology.Design and Synthesis of Novel, Selective GPR40 AgoPAMs.
P2860
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
@en
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists.
@nl
type
label
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
@en
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists.
@nl
prefLabel
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
@en
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists.
@nl
P2093
P2860
P356
P1476
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists
@en
P2093
An-Rong Li
Daniel C-H Lin
Gayathri Swaminath
Jane Zhang
Jiwen Jim Liu
Jonathan B Houze
Julio C Medina
Liusheng Zhu
P2860
P304
P356
10.1021/ML4005123
P577
2014-02-03T00:00:00Z